Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond C Chang

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Quarterly Journal of Experimental Psychology. B, Comparative and Physiological Psychology|December 24, 2003
Comparing excitatory backward and forward conditioningRaymond C Chang, Steven Stout, Ralph R Miller
Journal of Experimental Psychology. Animal Behavior Processes|July 30, 2003
Backward conditioning: mediation by the contextRaymond C Chang, Aaron P Blaisdell, Ralph R Miller
Learning & Behavior|January 22, 2004
Massive preexposure and preexposure in multiple contexts attenuate the context specificity of latent inhibitionDaniel S Wheeler, Raymond C Chang, Ralph R Miller
Synapse (New York, N.Y.)|April 21, 2007
In vitro and in vivo binding of neuroactive steroids to the sigma-1 receptor as measured with the positron emission tomography radioligand [18F]FPSRikki N Waterhouse, Raymond C Chang, Nana Atuehene, et al.
Nuclear Medicine and Biology|March 21, 2006
In vivo evaluation in rats of [(18)F]1-(2-fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine as a potential radiotracer for PET assessment of CNS sigma-1 receptorsRikki N Waterhouse, Raymond C Chang, Jun Zhao, et al.
Advances in Therapy|July 3, 2024
Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic SyndromeRaymond C Chang, Ryan L Miller, Katherine W Kwon, et al.
Frontiers in Cardiovascular Medicine|June 29, 2026
Patterns and risk factors of hyperkalemia recurrence among heart failure patientsChristopher G Rowan, Geraldine Francisco, Raymond C Chang, et al.
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
Benefits of dapagliflozin in chronic kidney disease for US commercial payers: A cost-offset analysisRaymond C Chang, Joanna Huang, James Hurst, et al.
Journal of the American College of Emergency Physicians Open|November 11, 2024
Management of factor Xa inhibitor-related traumatic non-intracranial bleeding events with andexanet alfa or four-factor prothrombin complex concentrate in a US multicenter observational studyPaul P Dobesh, Craig I Coleman, Mark Danese, et al.
Molecular Imaging and Biology|August 23, 2006
Preclinical acute toxicity studies and dosimetry estimates of the novel sigma-1 receptor radiotracer, [18F]SFERikki N Waterhouse, Jun Zhao, Michael G Stabin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Quarterly Journal of Experimental Psychology. B, Comparative and Physiological Psychology|December 24, 2003
Comparing excitatory backward and forward conditioningRaymond C Chang, Steven Stout, Ralph R Miller
Journal of Experimental Psychology. Animal Behavior Processes|July 30, 2003
Backward conditioning: mediation by the contextRaymond C Chang, Aaron P Blaisdell, Ralph R Miller
Learning & Behavior|January 22, 2004
Massive preexposure and preexposure in multiple contexts attenuate the context specificity of latent inhibitionDaniel S Wheeler, Raymond C Chang, Ralph R Miller
Synapse (New York, N.Y.)|April 21, 2007
In vitro and in vivo binding of neuroactive steroids to the sigma-1 receptor as measured with the positron emission tomography radioligand [18F]FPSRikki N Waterhouse, Raymond C Chang, Nana Atuehene, et al.
Nuclear Medicine and Biology|March 21, 2006
In vivo evaluation in rats of [(18)F]1-(2-fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine as a potential radiotracer for PET assessment of CNS sigma-1 receptorsRikki N Waterhouse, Raymond C Chang, Jun Zhao, et al.
Advances in Therapy|July 3, 2024
Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic SyndromeRaymond C Chang, Ryan L Miller, Katherine W Kwon, et al.
Frontiers in Cardiovascular Medicine|June 29, 2026
Patterns and risk factors of hyperkalemia recurrence among heart failure patientsChristopher G Rowan, Geraldine Francisco, Raymond C Chang, et al.
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
Benefits of dapagliflozin in chronic kidney disease for US commercial payers: A cost-offset analysisRaymond C Chang, Joanna Huang, James Hurst, et al.
Journal of the American College of Emergency Physicians Open|November 11, 2024
Management of factor Xa inhibitor-related traumatic non-intracranial bleeding events with andexanet alfa or four-factor prothrombin complex concentrate in a US multicenter observational studyPaul P Dobesh, Craig I Coleman, Mark Danese, et al.
Molecular Imaging and Biology|August 23, 2006
Preclinical acute toxicity studies and dosimetry estimates of the novel sigma-1 receptor radiotracer, [18F]SFERikki N Waterhouse, Jun Zhao, Michael G Stabin, et al.
Pageof 2